BRD4 and non-small cell lung carcinoma: In conclusion, we demonstrate that inhibition of BRD4 suppresses APT1 expression and subsequently promotes MST1 palmitoylation and blocks the nuclear translocation of YAP1, thereby sensitizing NSCLC cells to osimertinib.